Amgen Inc.

AMGN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Market Cap$151,824$150,215$167,614$140,880
- Cash$9,445$8,028$8,810$11,973
+ Debt$54,587$56,204$57,381$60,099
Enterprise Value$196,966$198,391$216,185$189,006
Revenue$9,557$9,167$8,149$9,086
% Growth4.3%12.5%-10.3%
Gross Profit$6,475$6,156$5,181$5,974
% Margin67.8%67.2%63.6%65.7%
EBITDA$5,913$3,617$4,083$2,926
% Margin61.9%39.5%50.1%32.2%
Net Income$3,216$1,432$1,730$627
% Margin33.7%15.6%21.2%6.9%
EPS Diluted5.932.653.21.16
% Growth123.8%-17.2%175.9%
Operating Cash Flow$4,684$2,280$1,391$4,771
Capital Expenditures-$436-$369-$411-$371
Free Cash Flow$4,248$1,911$980$4,400
Amgen Inc. (AMGN) Financial Statements & Key Stats | AlphaPilot